0001299130-24-000173.txt : 20240820
0001299130-24-000173.hdr.sgml : 20240820
20240820172701
ACCESSION NUMBER: 0001299130-24-000173
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240819
FILED AS OF DATE: 20240820
DATE AS OF CHANGE: 20240820
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eidel Jeff
CENTRAL INDEX KEY: 0001942024
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34899
FILM NUMBER: 241226376
MAIL ADDRESS:
STREET 1: 1305 O'BRIEN DR.
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CENTRAL INDEX KEY: 0001299130
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 161590339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1305 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-521-8000
MAIL ADDRESS:
STREET 1: 1305 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC
DATE OF NAME CHANGE: 20050829
FORMER COMPANY:
FORMER CONFORMED NAME: NANOFLUIDICS INC
DATE OF NAME CHANGE: 20040729
4
1
wk-form4_1724189215.xml
FORM 4
X0508
4
2024-08-19
0
0001299130
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PACB
0001942024
Eidel Jeff
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1305 O'BRIEN DRIVE
MENLO PARK
CA
94025
0
1
0
0
See Remarks
0
Common Stock
2024-08-19
4
S
0
26760
1.592
D
869730
D
Common Stock
208
I
By spouse
Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
This sale price represents the weighted average sale price of the shares sold ranging from $1.58 to $1.63 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Includes 3,128 shares purchased on March 1, 2024 under the Company's 2010 Employee Stock Purchase Plan.
Chief Commercial Officer
/s/ Michele Farmer, Attorney-in-fact
2024-08-20